One of the biggest hurdles in gene therapy is safely and efficiently delivering the editing tools into the target cells. Breakthroughs have come with limitations — but this collaboration...

To read the full story on AllPennyStocks.com, click here.

SOHM (PK) (USOTC:SHMN)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025 Click aqui para mais gráficos SOHM (PK).
SOHM (PK) (USOTC:SHMN)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025 Click aqui para mais gráficos SOHM (PK).